Overall Survival, Braf, Ras, and Msi Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer
AuthID
P-00Y-ZJ2
P-00Y-ZJ2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service